ArticleCancer chemotherapy and pharmacology2021

Demethoxycucumin protects MDA-MB-231 cells induced bone destruction through JNK and ERK pathways inhibition.

Xiaofeng Shen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.